Trades on 1 secondary market
Leyden Labs
Leyden Labs is a clinical-stage biotechnology company headquartered in Leiden, The Netherlands, with a regional office in Singapore, developing intranasal antibody products that protect people against known and newly emerging respiratory viruses. Its approach pairs mucosal immunity — delivering anti
Leyden Labs is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.